Level D· Scientific groundwork from lab and animal studiesAnimal StudyPubMed

Human adult mesenchymal stem cells improve rat spatial cognitive function after systemic hemorrhagic shock.

Plaschke K.

Animal Study on Systemic / IV, published in Behav Brain Res (2009) — summary generated from the PubMed abstract.

Open my reading list
Level D· Scientific groundwork from lab and animal studiesEvidence level of this study

Evidence from laboratory and animal studies provides groundwork for understanding mechanisms and potential before human studies continue.

  • Level A · Stronger Clinical Evidence
  • Level B · Emerging clinical evidence with positive signals
  • Level C · Early human research exploring benefits
  • Level D · Scientific groundwork from lab and animal studies
  • Emerging · Emerging topic under active research
Read the A–D evidence level guide

This page is generated from the PubMed record. The Thai description is an automated summary of bibliographic fields and the abstract, not a full translation, and is not medical advice.

Study type
Animal Study
Journal
Behav Brain Res (2009)
Country
Netherlands
Reported sample size
—
Source database
PubMed
PMID
19428653
DOI
10.1016/j.bbr.2009.03.009
Citations
5

Abstract (original English)

The aim of the present study was to examine whether a single infusion of human adult mesenchymal stem cells (hMSC) has protective effects on rat cognitive functions after systemic hemorrhagic shock. Systemic hemorrhagic rat shock model of pronounced (30 min) systemic hypotension [30-40 mmHg mean arterial blood pressure (MABP) reduction] was used to induce cerebral oligemia. Immediately after the experimental transient hypotension period ended, human processed lipoaspirate-derived mesenchymal stem cells (hMSC, 1 x 10(6)) were administered via the femoral vein. Rats were tested in relation to their cognitive spatial abilities using the Morris water maze before and 3 days after transient oligemia and with/without hMSC transplantation. Immunohistological investigations were performed with respect to apoptosis and BrdU staining. A clear functional improvement was observed in the rats' spatial cognitive abilities after hypotension and subsequent hMSC transplantation. In the hypotension group, hMSC infusion reduced the mortality from 50% to 25%. Six days after hMSC administration and hypotension, we did not detect any BrdU-labeled cells in rat brain, lung, and liver; however, BrdU-positive cells were found in spleen. No signs of cerebral apoptosis were observed. We conclude from this study that hMSCs derived from peripheral blood could be an important cell source to improve functional

What this study does not prove

  • • This study does not prove SVF is an approved treatment or a replacement for standard care.
  • • This is preclinical work; animal or laboratory results cannot be applied to humans.

Evidence level

Evidence from laboratory and animal studies provides groundwork for understanding mechanisms and potential before human studies continue.

How we grade evidence
AdultAdult Stem CellsAnalysis of VarianceAnimalsBrainBrain Damage, ChronicHumansHypotensionMaleMaze Learning

Browse all related research

Filter the research library by this study's title keywords, author, or publication year.

Related research